CytomX Therapeutics (CTMX) Interest Coverage Ratio Growth (3y) (2017 - 2025)
CytomX Therapeutics (CTMX) Interest Coverage Ratio Growth (3y) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -11.54% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 82.53% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 43.08% |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 28.57% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -26.00% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -24.77% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 33.30% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 81.16% |
| 10 | CytomX Therapeutics | 732.14 Mn | 401.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -546.55% |
| Sep 30, 2025 | 56.14% |
| Jun 30, 2025 | 78.64% |
| Mar 31, 2025 | 28.61% |
| Dec 31, 2024 | 26.08% |
| Sep 30, 2024 | 26.85% |
| Jun 30, 2024 | 23.88% |
| Mar 31, 2024 | 29.32% |
| Dec 31, 2023 | 94.33% |
| Sep 30, 2023 | 27.13% |
| Dec 31, 2022 | 57.75% |
| Sep 30, 2022 | -20.53% |
| Jun 30, 2022 | 0.07% |
| Mar 31, 2022 | -36.40% |
| Dec 31, 2021 | -347.01% |
| Sep 30, 2021 | 42.47% |
| Jun 30, 2021 | 62.07% |
| Mar 31, 2021 | 37.96% |
| Dec 31, 2020 | -816.67% |
| Sep 30, 2020 | -287.47% |